PCI Biotech Holding Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Ronny Skuggedal
Chief executive officer
NOK 2.4m
Total compensation
| CEO salary percentage | 82.8% |
| CEO tenure | 11.2yrs |
| CEO ownership | 0.1% |
| Management average tenure | no data |
| Board average tenure | 8.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -NOK 16m |
| Mar 31 2024 | n/a | n/a | -NOK 18m |
| Dec 31 2023 | NOK 2m | NOK 2m | -NOK 20m |
| Sep 30 2023 | n/a | n/a | -NOK 23m |
| Jun 30 2023 | n/a | n/a | -NOK 29m |
| Mar 31 2023 | n/a | n/a | -NOK 38m |
| Dec 31 2022 | NOK 2m | NOK 2m | -NOK 55m |
| Sep 30 2022 | n/a | n/a | -NOK 73m |
| Jun 30 2022 | n/a | n/a | -NOK 84m |
| Mar 31 2022 | n/a | n/a | -NOK 88m |
| Dec 31 2021 | NOK 2m | NOK 2m | -NOK 88m |
| Sep 30 2021 | n/a | n/a | -NOK 90m |
| Jun 30 2021 | n/a | n/a | -NOK 90m |
| Mar 31 2021 | n/a | n/a | -NOK 100m |
| Dec 31 2020 | NOK 3m | NOK 1m | -NOK 72m |
| Sep 30 2020 | n/a | n/a | -NOK 71m |
| Jun 30 2020 | n/a | n/a | -NOK 64m |
| Mar 31 2020 | n/a | n/a | -NOK 61m |
| Dec 31 2019 | NOK 2m | NOK 1m | -NOK 89m |
| Sep 30 2019 | n/a | n/a | -NOK 68m |
| Jun 30 2019 | n/a | n/a | -NOK 62m |
| Mar 31 2019 | n/a | n/a | -NOK 43m |
| Dec 31 2018 | NOK 2m | NOK 1m | -NOK 35m |
| Sep 30 2018 | n/a | n/a | -NOK 46m |
| Jun 30 2018 | n/a | n/a | -NOK 48m |
| Mar 31 2018 | n/a | n/a | -NOK 48m |
| Dec 31 2017 | NOK 1m | NOK 1m | -NOK 43m |
Compensation vs Market: Ronny's total compensation ($USD221.39K) is below average for companies of similar size in the German market ($USD478.33K).
Compensation vs Earnings: Ronny's compensation has increased whilst the company is unprofitable.
CEO
Ronny Skuggedal (48 yo)
11.2yrs
Tenure
NOK 2,443,000
Compensation
Mr. Ronny Skuggedal has been the Chief Financial Officer at PCI Biotech Holding ASA and PCI Biotech AS since joining in October 2013. He serves as Chief Executive Officer at PCI Biotech Holding ASA since S...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman | 9.6yrs | NOK 395.00k | 0.33% € 15.9k | |
| Independent Director | 8.6yrs | NOK 260.00k | 0.035% € 1.7k | |
| Independent Director | 5.6yrs | NOK 260.00k | no data |
8.6yrs
Average Tenure
69yo
Average Age
Experienced Board: 4QG's board of directors are considered experienced (8.6 years average tenure).